16
total announcements
ZIMLAB.NS · 15 min delayed
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about the transcript of Q1 FY27 Earnings Conference Call, where the management discussed the company's financial results, EU-GMP remediation process, and business outlook.
Zim Laboratories Limited
Zim Laboratories Limited has submitted the Exchange a copy Scrutinizer report of Postal Ballot. The company has informed the Exchange regarding voting results. The Special Resolutions as proposed in the notice of the Postal Ballot were passed by the Members with requisite majority.
Zim Laboratories Limited
Zim Laboratories Limited has made the audio recording of its Q1 FY27 earnings conference call available on its website.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about the publication of financial results for the quarter ended 30.06.2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about Earnings Presentation - Q1 FY27, with Q1 FY27 financial highlights showing a 31.2% increase in total operating income and a 40.0% decrease in EBITDA.
Zim Laboratories Limited
Zim Laboratories Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which includes revenue from operations of Rs. 9,417.85 lakhs and total income of Rs. 9,517.08 lakhs. The company's expenses include cost of materials consumed of Rs. 4,381.61 lakhs and total expenses of Rs. 5,432.52 lakhs. The results are subject to a limited review by Deloitte Haskins & Sells LLP.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about the schedule of a Q1FY27 Earnings Conference Call to be held on Friday, 07th August, 2026 at 12:00 p.m. IST. The call will be hosted by Go India Advisors and will feature company participants Mr. Zulfiquar Kamal, Mr. Shyam Mohan Patro, and Mr. Zain Daud.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about the transfer of equity shares to Investor Education and Protection Fund (IEPF) Account, as per the requirements of Section 124(6) of the Companies Act, 2013, and Rule 6(3) of the Investor Education and Protection Fund (IEPF) Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange regarding allotment of 109451 securities pursuant to ESOP/ESPS at its meeting held on July 13, 2026, increasing the paid-up equity share capital from Rs. 53,54,90,370 to Rs. 53,65,84,880.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance under Regulation 74(5) for the quarter ended on 30th June, 2026.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot for seeking approval of the Members of the Company on the Special Resolution forming part of the Notice.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about the schedule of an Investors / Analysts Meet, to be held on July 3, 2026, with Canara HSBC Life Insurance. The meeting is subject to change due to exigencies, and no unpublished price sensitive information will be shared.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange about the schedule of an Investors / Analysts Meet on July 3rd, 2026, with Tata Asset Management Pvt. Ltd.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange regarding voting results of Annual General Meeting held on Jun 29, 2026.
Zim Laboratories Limited
Zim Laboratories Limited held its 42nd Annual General Meeting on June 29, 2026, through video conferencing. The meeting was conducted in accordance with the Companies Act, 2013, and the circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The Company Secretary provided general instructions to the members regarding participation in the meeting and e-voting. The meeting was attended by the Chairman, Managing Director, Whole Time Directors, and Independent Directors. The Statutory Auditors and Secretarial Auditors submitted reports without any qualifications or adverse remarks. The Company provided the facility to cast votes electronically on all the resolutions set forth in the notice.
Zim Laboratories Limited
Zim Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for dealing with securities of the Company will remain closed from Wednesday, the 01st July, 2026, for Designated Persons and their immediate relatives. The Trading Window shall open post 48 hours from the declaration of financial results of the Company for the quarter ended 30th June, 2026.